Hypersusceptibility to Azole Antifungals in a Clinical Isolate of Candida glabrata with Reduced Aerobic Growth
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Petite mutations have been described in Saccharomyces cerevisiae and pathogenic yeasts. However, previous studies of the phenotypic traits of these petite mutants reported that they express azole resistance. We describe a clinical isolate of Candida glabrata with a striking association between increased susceptibility to azoles and respiratory deficiency. This isolate was obtained from a urine sample together with a respiration-competent C. glabrata isolate which exhibited azole resistance. The respiratory status of the two isolates was confirmed by cultivation on glycerol-containing agar and oxygraphy. Flow cytometry revealed the normal incorporation of rhodamine 123, and mitochondrial sections with typical cristae were seen by transmission electron microscopy for both isolates. Together, these results suggested a nuclear origin for the reduced respiratory capacity of the hypersusceptible isolate. The sterol contents of these isolates were similar to the sterol content of a reference strain. Sequencing of the ERG11 and PDR1 genes revealed that the sequences were identical in the two isolates, demonstrating their close relatedness. In addition to silent mutations, they carried a nonsense mutation in PDR1 that led to the truncation of transcription factor Pdr1p. They also overexpressed both PDR1 and one of its targets, CDR1 , providing a possible explanation for the azole resistance of the respiration-competent isolate. In conclusion, in addition to azole resistance, which is a common feature of C. glabrata mitochondrial petite mutants, the mutation of a nuclear gene affecting aerobic growth may lead to azole hypersusceptibility; however, the mechanisms underlying this phenotype remain to be determined.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mitochondrial dysfunction in pathogenic fungi or model yeast causes altered susceptibilities to antifungal drugs.”
From Azole Susceptibility and Transcriptome Profiling in Candida albicans Mitochondrial Electron Transport Chain Complex I Mutants (2013) · cites this paper as [12]
In the citing paper
“An association of decreased fluconazole susceptibility with mitochondrial dysfunction in C. glabrata has been reported by several laboratories (7–12).”
From Azole Susceptibility and Transcriptome Profiling in Candida albicans Mitochondrial Electron Transport Chain Complex I Mutants (2013) · cites this paper as [12]
Citations
Cites
Systematic screen for human disease genes in yeast
Steinmetz, L. M., Scharfe, C., Deutschbauer, A. M., Mokranjac, D., Herman, Z. S., Jones, T., Chu, A. M., Giaever, G., Prokisch, H., Oefner, P. J., et al. (2002) · Nature Genetics · doi:10.1038/ng929 · Cited by 544 · cited 2×
“(21) reported that deletion of any of 201 of 353 genes known to encode proteins involved in mitochondrial function or biogen-”
BackgroundGenetic Basis of Mitochondrial Function and Morphology in Saccharomyces cerevisiae
Dimmer, K. S., Fritz, S., Fuchs, F., Messerschmitt, M., Weinbach, N., Neupert, W., & Westermann, B. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-12-0588 · Cited by 445 · cited 1×
“(12) identified 64 genes whose deletion severely impaired growth on nonfermentative culture media but did not abolish respiration.”
BackgroundCoste, A. T., Karababa, M., Ischer, F., Bille, J., & Sanglard, D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1639-1652.2004 · Cited by 407 · cited 1×
“this transcription factor have not been clearly described (3, 11).”
BackgroundCoste, A., Turner, V., Ischer, F., Morschhäuser, J., Forche, A., Selmecki, A., Berman, J., Bille, J., & Sanglard, D. (2006) · Genetics · doi:10.1534/genetics.105.054767 · Cited by 385 · cited 1×
“The increased activity of Tac1p may also be due to a gain-of-function mutation of the TAC1 gene (10).”
BackgroundA nuclear receptor-like pathway regulating multidrug resistance in fungi
Thakur, J. K., Arthanari, H., Yang, F., Pan, S.-J., Fan, X., Breger, J., Frueh, D. P., Gulshan, K., Li, D. K., Mylonakis, E., et al. (2008) · Nature · doi:10.1038/nature06836 · Cited by 343 · cited 1×
“cerevisiae demonstrate that the C terminus of Pdr1p contains a domain that can induce the expression of PDR genes in the presence of azoles (22), suggesting a decreased activity of the truncated transcription factor in the presence of azole drugs.”
BackgroundThe Mitochondrial Genotype Can Influence Nuclear Gene Expression in Yeast
Parikh, V. S., Morgan, M. M., Scott, R., Clements, L. S., & Butow, R. A. (1987) · Science · doi:10.1126/science.3027892 · Cited by 324 · cited 1×
“Brun et al. (6) suggested that given the close communication between the nuclear and the mitochondrial genomes ( 16 , 23), deregulation of the expression of the gene encoding the ABC membrane transporter (Cdr1p) in C. glabrata petite mutants and, consequently, their azole resistance may be linked to the absence of mit…”
BackgroundGenotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates
Coste, A., Selmecki, A., Forche, A., Diogo, D., Bougnoux, M.-E., d'Enfert, C., Berman, J., & Sanglard, D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00151-07 · Cited by 305 · cited 2×
“albicans, the expression of the PDR transcription factor Tac1p can be increased by duplication of the entire chromosome harboring the TAC1 gene (9).”
BackgroundFerrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., & Sanglard, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000268 · Cited by 295 · cited 1×
“For example, the Y584C mutation leads to the upregulation of CDR1 but does not affect CDR2 expression, as was observed in our clinical isolate (14).”
BackgroundAntifungal agents: mode of action in yeast cells.
Carrillo‐Muñoz, A. J., Giusiano, G., Ezkurra, P. A., & Quindós, G. (2006) · PubMed · Cited by 293
The multidrug resistance gene PDR1 from Saccharomyces cerevisiae.
Balzi, E., Chen, W., Ulaszewski, S., Capieaux, E., & Goffeau, A. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45464-6 · Cited by 276 · cited 1×
“this transcription factor have not been clearly described (3, 11).”
BackgroundSanglard, D., Ischer, F., & Bille, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1174-1183.2001 · Cited by 247 · cited 4×
“glabrata, which may also occur in vivo (4), exhibit decreased susceptibilities to azole antifungals (6, 19).”
BackgroundInfluentialTsai, H.-F., Krol, A. A., Sarti, K. E., & Bennett, J. E. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1384-1392.2006 · Cited by 237 · cited 9×
“One may speculate that the nonsense mutation in the PDR1 gene of the azole-resistant isolate disrupts the Pdr1p domains required to activate the expression of HSP12 and CDR2.”
BackgroundInfluentialVermitsky, J., Earhart, K. D., Smith, W. L., Homayouni, R., Edlind, T. D., & Rogers, P. D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05235.x · Cited by 233 · cited 2×
“Surprisingly, another gene encoding an ABC efflux pump, CDR2, was not overexpressed in the resistant isolate, although this gene contains a pleiotropic drug-responsive element (PDRE) in its promoter and has been reported to be regulated by Pdr1p (27).”
BackgroundTraven, A., Wong, J. M. S., Xu, D., Sopta, M., & Ingles, C. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006807200 · Cited by 213 · cited 1×
“Brun et al. (6) suggested that given the close communication between the nuclear and the mitochondrial genomes (16, 23 ), deregulation of the expression of the gene encoding the ABC membrane transporter (Cdr1p) in C. glabrata petite mutants and, consequently, their azole resistance may be linked to the absence of mito…”
BackgroundPraekelt, U. M., & Meacock, P. A. (1990) · Molecular and General Genetics MGG · doi:10.1007/bf00315801 · Cited by 184
Mechanisms of Azole Resistance in Petite Mutants of Candida glabrata
Brun, S., Bergès, T., Poupard, P., Vauzelle-Moreau, C., Renier, G., Chabasse, D., & Bouchara, J.-P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1788-1796.2004 · Cited by 151 · cited 7×
“This azole resistance is due to the overexpression of various ATP-binding cassette (ABC) efflux pumps (6, 19) linked to the upregulation of the transcription factor Pdr1p (24).”
BackgroundMethodInfluentialSelf-citationMechanisms of Azole Resistance in a Clinical Isolate of Candida tropicalis
Vandeputte, P., Larcher, G., Bergès, T., Renier, G., Chabasse, D., & Bouchara, J.-P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4608-4615.2005 · Cited by 141 · cited 2×
“, Norfolk, England), as described previously (25).”
MethodSelf-citationTherapeutic Drug Monitoring of Voriconazole
Brüggemann, R. J. M., Donnelly, J. P., Aarnoutse, R. E., Warris, A., Blijlevens, N. M. A., Mouton, J. W., Verweij, P. E., & Burger, D. M. (2008) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31817b1a95 · Cited by 135 · cited 1×
“The plasma voriconazole concentration at the time of urine sampling was 1 mg/liter, which corresponds to the lower limit of the therapeutic range (1 to 6 mg/liter), as recently proposed by Bru ¨ggemann et al. ( 5 ).”
MethodVandeputte, P., Tronchin, G., Bergès, T., Hennequin, C., Chabasse, D., & Bouchara, J.-P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01510-06 · Cited by 109 · cited 4×
“glabrata isolates 22852 and 22853 were determined as described previously (26).”
MethodInfluentialSelf-citationAntifúngicos: mecanismo de acción en células de levaduras
Quindós, G., Giusiano, G., Ezkurra, P. A., & Muñoz, A. J. C. (2006) · Revista española de quimioterapia. Suplemento · Cited by 102
Clinical relevance of mechanisms of antifungal drug resistance in yeasts
Sanglard, D. (2002) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(02)72842-5 · Cited by 98 · cited 2×
“The increased susceptibility to azoles of this clinical isolate, despite the overexpression of CDR1, is quite surprising, since the overexpression of ABC-coding genes is the most frequent mechanism of resistance to azole drugs found in clinical isolates of Candida yeasts (18).”
BackgroundIn-vivo selection of an azole-resistant petite mutant of Candida glabrata
BOUCHARA, J.-P., LE BOUDOUIL, S., FILMON, R., ZOUHAIR, R., HALLET, J.-N., CHABASSE, D., RENIER, G., & DEFONTAINE, A. (2000) · Journal of Medical Microbiology · doi:10.1099/0022-1317-49-11-977 · Cited by 88 · cited 2×
“glabrata, which may also occur in vivo (4), exhibit decreased susceptibilities to azole antifungals (6, 19).”
BackgroundSelf-citationMitoP2, an integrated database on mitochondrial proteins in yeast and man
Andreoli, C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh137 · Cited by 83 · cited 2×
“About 40 genes encode enzymes of the mitochondrial respiratory chain, but only 7 of them are mitochondrial (1).”
BackgroundKontoyiannis, D. P. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.2.191 · Cited by 70 · cited 1×
“As in Saccharomyces cerevisiae (15) and C.”
Cheng, S., Clancy, C. J., Nguyen, K. T., Clapp, W., & Nguyen, M. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00182-07 · Cited by 62 · cited 1×
“Unlike Candida albicans, in which mutations that result in the petite phenotype occur under a very limited range of conditions (2, 8), Candida glabrata produces petite mutants with a high frequency in vitro (6, 19).”
BackgroundFlow cytometry as a tool to discriminate respiratory-competent and respiratory-deficient yeast cells
Skowronek, P., Krummeck, G., Haferkamp, O., & Rödel, G. (1990) · Current Genetics · doi:10.1007/bf00318391 · Cited by 46 · cited 1×
“The incorporation of this fluorochrome into mitochondria is dependent on the potential difference between the intermembrane space and the mitochondrial lumen, and therefore, the level of fluorochrome incorporation allows the detection of a defect in the electron flow through the mitochondrial respiratory chain ( 20 ).”
BackgroundInduction of petite mutation with acriflavine and elevated temperature in Candida albicans
Aoki, S., & Ito-Kuwa, S. (1987) · Medical Mycology · doi:10.1080/02681218780000611 · Cited by 36 · cited 3×
“Samples for electron microscopy were processed by the method of Aoki and Ito-Kuwa (2), with slight modifications, as described previously (4).”
BackgroundMethod
Research works printed but not linked: 1
- Ephrussi, B., H. Hottinguer, and J. Tavlitzki. 1949. Action de l'acriflavine sur les levures. II. Etude génétique du mutant “petite colonie.” Ann. Inst. Pasteur76:419-450.
Cited by
Shingu-Vazquez, M., & Traven, A. (2011) · Eukaryotic Cell · doi:10.1128/ec.05184-11 · Cited by 209
“While the resistance to azole drugs that is associated with some mitochondrial mutations is a concern, it has to be noted that resistance is only seen with specific mutations, and several mitochondrial mutants are known which are sensitive to the azoles (22, 38, 86).”
BackgroundInfluentialHull, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06253-11 · Cited by 113
“glabrata exhibiting hypersusceptibility to azoles and polyenes have also been identified (39).”
BackgroundSun, N., Fonzi, W., Chen, H., She, X., Zhang, L., Zhang, L., & Calderone, R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01520-12 · Cited by 94
“glabrata exhibited hypersusceptibility to several azoles (12).”
Verma, S., Shakya, V. P. S., & Idnurm, A. (2018) · Virulence · doi:10.1080/21505594.2017.1414133 · Cited by 67
“While a limited set of mitochondrial dysfunctional states or specific mutations induce azole drug resistance, for a few they cause increased drug susceptibility, even with the increased expression of efflux pumps [94].”
BackgroundFungicidal effect of thymoquinone involves generation of oxidative stress in Candida glabrata
Almshawit, H., & Macreadie, I. G. (2016) · Microbiological Research · doi:10.1016/j.micres.2016.11.008 · Cited by 63
Metadata
- Authors
- Vandeputte, P., Tronchin, G., Rocher, F., Renier, G., Bergès, T., Chabasse, D., & Bouchara, J.-P.
- Affiliations
- Université d'Angers (FR)
- Laboratoire Synthèse et Réactivité des Substances Naturelles, UMR 6514, Université de Poitiers, Poitiers, France
- Groupe d'Etude des Interactions Hôte-Pathogène, UPRES-EA 3142, Université d'Angers, Angers, France
- Physiologie Moléculaire des Transporteurs de Sucre, FRE 3091, Faculté des Sciences, Poitiers Cedex 86022, France
- Corresponding author
- Vandeputte, Patrick
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2009-07
- Volume
- 53
- Issue
- 7
- Pages
- 3034-3041
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2704708
- OpenAlex
- W2110612528
- Cited by
- 26
- References
- 27
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 3 · 2014: 1 · 2013: 4 · 2012: 3
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- Candida glabrata, azole resistance, petite mutants, nonsense mutation, ERG11, PDR1, aerobic growth, sterol content, clinical isolates
- MeSH terms
- Adult, Aerobiosis, Antifungal Agents, Azoles, Chromatography, High Pressure Liquid, Ergosterol, Female, Flow Cytometry, Genes, Fungal, Humans, Microbial Sensitivity Tests, Molecular Sequence Data, Polyenes, Candida glabrata, Microscopy, Electron, Transmission
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.